AI assistant
Sending…
Whitehawk Therapeutics, Inc. — Director's Dealing 2021
Sep 22, 2021
34276_dirs_2021-09-22_94387c05-4f3a-4fab-a605-4aabaad2cf90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aadi Bioscience, Inc. (AADI)
CIK: 0001422142
Period of Report: 2021-09-20
Reporting Person: Delaney Brendan (Chief Operating Officer)
More from Whitehawk Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Director's Dealing
2025
Dec 2
Director's Dealing
2025
Dec 2
Regulatory Filings
2025
Nov 6
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Aug 25
Regulatory Filings
2025
Aug 7